Assessment of the Efficacy and Tolerance, and Health Economic Study of a Single Administration of Pegfilgrastim in Lymphoma or Myeloma Patients Treated With Intensive Chemotherapy and Autologous Peripheral Stem Cell Transplantation.
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2013
At a glance
- Drugs Pegfilgrastim (Primary) ; Filgrastim
- Indications Febrile neutropenia
- Focus Therapeutic Use
- Acronyms PALM
- 23 Feb 2013 Results of an economic analysis published in the Applied Health Economics and Health Policy.
- 13 Jul 2011 Cost-effectiveness results presented at the 8th World Congress of the International Health Economics Association: Transforming Health and Economics.
- 25 May 2011 Cost-effectiveness results presented at the 16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.